Arbeitspapier
Accounting for Moral Hazard In Cost-Effectiveness Analysis
In the paper, we use the theory of mechanism design to exhibit the cost of efficient provision of healthcare, defined as the uniquely defined sum of individual side payments which would eliminate moral hazard. It is argued that this cost may be used to assess the costs arising from use of the treatment in cases where it is not appropriate from a strictly medical point of view. An example is given to indicate how this assessment might enter into practical cost-effectiveness analysis.
- Language
-
Englisch
- Bibliographic citation
-
Series: Working paper ; No. 5-2007
- Classification
-
Wirtschaft
- Event
-
Geistige Schöpfung
- (who)
-
Keiding, Hans
Hansen, Bodil O.
- Event
-
Veröffentlichung
- (who)
-
Copenhagen Business School (CBS), Department of Economics
- (where)
-
Frederiksberg
- (when)
-
2007
- Handle
- Last update
- 10.03.2025, 11:44 AM CET
Data provider
This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Arbeitspapier
Associated
- Keiding, Hans
- Hansen, Bodil O.
- Copenhagen Business School (CBS), Department of Economics
Time of origin
- 2007
Other Objects (12)
Moral Hazard
(M)oral hazard?
Intrinsic moral hazard
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Accounting for spatial variability in life cycle cost-effectiveness assessments of environmental impact abatement measures
Moral Hazard in Teams
The Moral Hazard Argument
Moral hazard and ambiguity
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
Accounting for non-historical cost
Moral Hazard
(M)oral hazard?
Intrinsic moral hazard
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Accounting for spatial variability in life cycle cost-effectiveness assessments of environmental impact abatement measures
Moral Hazard in Teams
The Moral Hazard Argument
Moral hazard and ambiguity
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
Accounting for non-historical cost
Moral Hazard
(M)oral hazard?
Intrinsic moral hazard
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Accounting for spatial variability in life cycle cost-effectiveness assessments of environmental impact abatement measures
Moral Hazard in Teams
The Moral Hazard Argument
Moral hazard and ambiguity
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence